AN INTRODUCTION OF DOPAMINE INTO CLIN-
ICAL MEDICINE arose from the recognition that the agent had unique effects on the peripheral circulation. Earlier studies with that sympathomimetic amine, the immediate precursor of l-norepinephrine, suggested that it had mixed alpha and beta adrenergic stimulating properties and closely resembled epinephrine in its pharmacologic activity. ' 15 This view was challenged by a number of investigators who showed that, unlike epinephrine, dopamine had a selective vasodilating effect on certain vascular beds due to action on specific dopamine receptors.6-9 Dopamineinduced vasodilatation, not abolished by propranolol, was shown in the renal, mesenteric, coronary and cerebral vascular beds but not in the denervated skeletal muscle vasculature.10 The vasodilatation was selectively antagonized by phenothiazines and butyrophenones."' 12 Our own studies and those of others have emphasized that the choice of a vasoactive agent in the critically ill patient frequently requires balancing cardiac and peripheral effects,'13-1 particularly in patients with decreased coronary wedge pressure and right atrial pressure decreased from 23 to 18 mm Hg (P < 0.05) and from 10 to 8 mm Hg (P < 0.01) respectively. Improvement in hemodynamic status by dopamine was associated with deterioration of myocardial metabolism. Myocardial oxygen extraction ratios and arterial-coronary sinus oxygen differences increased from 73 to 76% (P < 0.05) and from 13.02 to 14.19 ml/100 ml (P < 0.02) respectively. Myocardial lactate production increased from -8 to -15% (P = 0.05).
We conclude that dopamine improved cardiac performance at the expense of myocardial oxygenation and that dopamine is potentially harmful to actuely ischemic myocardium. Systemic vascular resistance, SVR, (dynes-seccm-') = mean arterial pressure minus right atrial pressure times 79.9 divided by cardiac output. Systolic ejection period, SEP (sec/beat) = interval between onset of the rise in arterial pressure and the, incisura. The interval was measured from the tracing obtained at 100 mm/sec paper speed from the proximal brachial or distal axillary artery. Systolic ejection rate, SER, (ml/sec/M2) = stroke index divided by systolic ejection period. Myocardial extraction Arterial-coronary sinus oxygen difference (ml/100 ml) Figure 1 shows that heart rate increased during dopamine administration in all patients; the mean changed from 95 to 118 beats/min. Systolic and mean arterial pressures increased in all but two patients, the averages from 78 to 97 mm Hg and 60 to 65 mm Hg respectively (see table) . Cardiac index uniformly increased, the average 0.56 L/min/M2. This increase of cardiac index was associated with a fall of the arterial-pulmonary artery oxygen difference, from an average of 6.84 to 5.67 ml/ 100 ml. Systemic vascular resistance decreased in six patients and remained essentially unchanged in two, the average changed from 1786 to 1483 dynes-sec-cm-5. Right atrial and pulmonary wedge pressures decreased from an average of 10 to 8 mm Hg and 23 to 18 mm Hg respectively. Systolic ejection rate increased an average of 28%. Atrial and ventricular irritability was enhanced or occurred in three of the eight patients and dopamine administration was stopped in one patient and dosage decreased in two. Urine output increased from an average of 20 to 76 ml/hr.
Myocardial oxygen extraction ratios ( fig. 2 ) and arterialcoronary sinus oxygen differences increased in six patients, remained essentially unchanged in one and decreased in one patient. The averages changed from 73 to 76% (P < 0.05) and from 13.02 to 14.19 ml/100 ml (P < 0.02) respectively (see table). Figure 2 demonstrates that the rate of myocardial lactate production increased in five of six patients producing lactate and remained unchanged in one. In two patients, lactate extraction remained below 10%. The average lactate extraction ratio changed from -8 to -15%. Myocardial free fatty acid extraction varied but remained low during dopamine infusion. fatty acid extraction. In three of these patients the rate of lactate production increased; it remained unchanged in one patient.
Five of the eight patients received dopamine until intraaortic counterpulsation was initiated (1-5 hours). After hemodynamic stabilization, heart catheterization and aortocoronary bypass surgery were performed. Four patients were discharged and are relatively well with mild restriction of activity. One patient died following surgery in a low cardiac output state. Three of the eight patients were not eligible for cardiac assistance because of gross cardiac enlargement and previous left ventricular failure. Dopamine temporarily improved the shock state; two succumbed in the hospital, one was discharged and died four months later with severe left ventricular failure. Discussion Shock associated with acute myocardial infarction represents severe impairment of ventricular performance and myocardial energy production. The controversy during the past years over the efficacy of various pharmacologic agents resulted in part from an overemphasis on the function of the heart with little consideration given to the factors governing the survival of ischemic myocardium. We have previously demonstrated that potent inotropic stimulation improvewd myocardial performance but deteriorated myocardial metabolism in patients in shock associated with acute myocardial infarction.15 Dopamine is a frequently used vasoactive agent in this patient category. Little information, however, is available about its effect on myocardial oxygenation in severe acute ischemic heart disease.
The hemodynamic effects of dopamine depend upon the dose administered and the condition of the patient. In our patients, the dose of dopamine necessary to improve arterial blood pressure and urine flow, also increased heart rate and contractility, two important determinants of myocardial oxygen consumption. The chronotropic and inotropic properties of dopamine are well known and reported in previous studies. Heart rate ranged between 100 and 140 beats/min when dopamine was infused at an average rate of 23 Ag/kg/min to hypotensive patients following cardiac surgery.2' In a very similar patient group, dopamine (5-10 ,ug/kg/min) raised heart rate from an average of 89 to 111 beats/min, four of the patients exhibiting a heart rate above 120 beats/min. Ten patients in shock associated with acute myocardial infarction showed a progressive increase in heart rate with increasing doses of dopamine; 7.5 Ag/kg/min increased heart rate from an average of 107 to 133 beats/min. Higher doses of dopamine caused tachyarrhythmias.2 Less marked but substantial increases in heart rate following dopamine administration are reported in the literature. [24] [25] [26] Evaluation of myocardial contractility during the administration of dopamine in the intact organism is complicated by concurrent changes in heart rate, afterload, and preload. Substantial increases in cardiac output and systolic ejection rate in our patient group with only moderate decreases in systemic vascular resistance strongly suggest that dopamine increased myocardial contractility. The positive inotropic properties of dopamine were observed experimentally in normal27 and ischemic28 myocardium. Thompson et al. 29 reported the optimal inotropic effect of dopamine in man to be between 5 and 30 ,ug/kg/min as indicated by increase in cardiac output, pulse pressure and by modest changes in mean arterial pressure and systemic vascular resistance. Increase in contractility by dopamine in man was also shown by significant shortening of the systolic pre-ejection period.0' 31 The efficacy of any therapeutic intervention in shock associated with acute myocardial infarction depends upon its balance between myocardial oxygen requirement and supply. Dopamine in our patient group improved ventricular performance at the expense of myocardial oxygenation. Myocardial oxygen extraction, abnormally high prior to treatment, further increased during dopamine infusion evidencing increased oxygen demand and inadequate increase in oxygen supply. The increased rate of myocardial lactate production indicates enhancement of anaerobic metabolism and is additional evidence of the inadequacy of myocardial oxygen supply in relationship to oxygen demand. Myocardial free fatty acid extraction ratios, low prior to dopamine infusion, decreased in four patients suggesting increased ischemia. [32] [33] [34] Although dopamine is a widely used therapeutic agent in myocardial infarction shock, little is known about its effect on oxygenation of acutely ischemic myocardium. Crexells et al.35 infused 10 ,g/kg/min dopamine to patients with more than 75% obstruction of one or more of the major coronary arteries and found no significant changes in myocardial metabolism. Myocardial lactate extraction ratios averaged 10% and 11I% prior to and during dopamine infusion. The trend of changes indicated a decrease in coronary sinus oxygen tension. These results should be considered with caution since they were based on sampling of mixed coronary sinus blood in patients with less ischemic myocardium than our patients had. Venous effluent from the stressed but normal myocardium of Crexells' patients may have overshadowed the effluent from the ischemic areas, thus masking abnormalities in myocardial metabolism. Forrester et al.,'8 studying the awake dog, found that infusion of 5-10 ,ug/kg/min dopamine after coronary occlusion consistently deteriorated myocardial metabolism. The rate of myocardial lactate production increased from an average of -69 to -92%. Other investigators observed an increase in infarct size and of ischemic injury by dopamine in experimental myocardial infarction, using the open chest dog preparation.3638
The clinical experience with dopamine in myocardial infarction shock has been variable. A number of investigatorS25' 29, 3942 demonstrated improvement in cardiovascular and renal hemodynamics during dopamine administration. A significant number of patients survived the shock state but only a few lived very long. Among 24 patients in cardiogenic shock treated with dopamine, ten had an acute myocardial infarction.4' Three of these ten patients survived the shock episode, but died within one month. Five of our patients received dopamine until intra-aortic counterpulsation was initiated. In the remaining three patients, dopamine temporarily improved the shock state. Two succumbed in the hospital, one was discharged and died four months later due to severe left ventricular failure. These results emphasize the experience of the past decade that although shock in myocardial infarction can be improved by inotropic agents or cardiac assistance, long-term survival requires improvement of coronary perfusion by aortocoronary bypass surgery.
Our observations indicate that dopamine in the doses required to increase arterial pressure and cardiac output exerts inotropic and chronotropic effects which are detrimental to acutely ischemic myocardium. Since improvement of peripheral circulation is worthless in the face of a deteriorating pump, dopamine should be used with caution in patients in shock associated with acute myocardial infarction.
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